Medicare Enrolled
Dr. Naeem Chavla, M.D.
Urology Physician · Richland, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chavla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chavla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chavla
Dr. Naeem Chavla is an urology physician in Richland, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chavla performed 13,123 Medicare services across 2,516 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chavla received a total of $5,653 from 23 pharmaceutical and/or device companies across 82 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chavla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in WA
$5,653 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,123
Medicare services
Top 4% in WA for urology physician
2,516
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~656 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, degarelix, 1 mg | 6,482 | $3 | $7 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
1,600 | $5 | $10 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,460 | $2 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,103 | $63 | $165 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
696 | $8 | $90 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
294 | $96 | $214 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
276 | $8 | $75 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
188 | $0 | $17 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
164 | $189 | $500 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
95 | $728 | $2,000 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
86 | $112 | $329 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
85 | $113 | $300 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
78 | $288 | $600 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
72 | $28 | $66 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
51 | $46 | $127 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
48 | $26 | $200 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
48 | $158 | $360 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $141 | $286 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
32 | $242 | $576 |
| New patient office visit, complex (60-74 min) | 30 | $177 | $407 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
23 | $1,055 | $2,500 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
22 | $264 | $800 |
| Insertion of temporary bladder tube | 21 | $36 | $99 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
21 | $190 | $450 |
| Temporary urethral stent insertion A temporary stent is placed in the urethra using an endoscope to keep the passage open. |
18 | $548 | $1,500 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
18 | $95 | $225 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
16 | $321 | $600 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
15 | $457 | $1,500 |
| Prostate tissue destruction using radiofrequency heated water vapor A procedure that destroys prostate tissue by using radiofrequency energy to heat water vapor. This method is applied to treat the prostate gland. |
13 | $1,395 | $4,000 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
12 | $67 | $525 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
12 | $19 | $31 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $139 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
69.7% medium
29.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,653
Total received (2018-2024)
Avg $808/year across 7 years
Top 21% in WA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
82
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,515 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$137 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,473
2023
$237
2022
$295
2021
$438
2020
$183
2019
$1,667
2018
$360
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$1,234
Teleflex LLC
$1,172
PROGENICS PHARMACEUTICALS, INC.
$29
Telix Pharmaceuticals
$22
UROGEN PHARMA, INC.
$16
Top 3 companies account for 98.4% of 2024 payments
All-time payments by company (2018-2024) ›
Teleflex LLC
$1,549
NeoTract Inc.
$1,376
PROCEPT BioRobotics Corporation
$1,234
Boston Scientific Corporation
$247
Janssen Biotech, Inc.
$199
BOSTON SCIENTIFIC CORPORATION
$198
IsoRay, Inc
$125
Bayer HealthCare Pharmaceuticals Inc.
$125
Endo Pharmaceuticals Inc.
$110
Janssen Scientific Affairs, LLC
$76
Allergan Inc.
$66
E.R. Squibb & Sons, L.L.C.
$65
Augmenix, Inc.
$63
Astellas Pharma US Inc
$63
PROGENICS PHARMACEUTICALS, INC.
$29
180 Medical, Inc.
$26
Telix Pharmaceuticals
$22
DENTSPLY IH Inc.
$20
UROGEN PHARMA, INC.
$16
PFIZER INC.
$15
Allergan, Inc.
$14
Janssen Pharmaceuticals, Inc
$9
Travere Therapeutics, Inc.
$4
Top 3 companies account for 73.6% of all-time payments
Associated products mentioned in payments ›
AQUABEAM SYSTEM · BOTOX · Brachytherapy Source · Erleada · JELMYTO · LoFric · OPDIVO · PYLARIFY · REZUM · Rezum Generator · SpaceOAR · SpaceOAR VUE System - 10mL · SpeediCath · Thiola · UROLIFT · UroLift · UroLift System · XIAFLEX · XTANDI · Xofigo · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
7
Per 100K population
3.3
County median income
$87,316
Nearest hospital
KADLEC REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chavla is a mixed practice specialist, with above-average Medicare volume (top 4% in WA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chavla experienced with injection, degarelix, 1 mg?
Based on Medicare claims data, Dr. Chavla performed 6,482 injection, degarelix, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chavla receive payments from pharmaceutical companies?
Yes. Dr. Chavla received a total of $5,653 from 23 companies across 82 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chavla's costs compare to other urology physicians in Richland?
Dr. Chavla's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chavla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Richland
Browse urology physicians in Richland ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in WA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in WA
Which WA urology physicians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology